Next‐generation Gene Silencers for Cancer Immunotherapy
In the tumor microenvironment, immune evasion entails a reciprocal interaction between cancer cells and T-cells. This leads to the inhibition of the tumor killing ability of T-cells via immune checkpoint protein interactions, mainly - PD-1/PD-L1 & CTLA-4/B7. [2nd Award]
Saved in:
主要作者: | Ng, Aik Seng |
---|---|
其他作者: | Navin Kumar Verma |
格式: | Student Research Poster |
語言: | English |
出版: |
2017
|
主題: | |
在線閱讀: | https://hdl.handle.net/10356/83907 http://hdl.handle.net/10220/42843 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|
機構: | Nanyang Technological University |
語言: | English |
相似書籍
-
NOVEL RNA-BASED CANCER VACCINE FOR AML IMMUNOTHERAPY
由: THAM GUO HONG
出版: (2024) -
A semiconducting iron-chelating nano-immunomodulator for specific and sensitized sono-metallo-immunotherapy of cancer
由: He, Shasha, et al.
出版: (2023) -
Combined inhibition of PD-1/PD-L1, Lag-3, and Tim-3 axes augments antitumor immunity in gastric cancer–T cell coculture models
由: Mimura, Kosaku, et al.
出版: (2022) -
IMMUNOTHERAPY TARGETING RON IN CANCER
由: KOH XIN YU
出版: (2017) -
Editorial: Next generation γδ T cell-based tumor immunotherapy
由: Tan, AHM, et al.
出版: (2024)